Loading clinical trials...
Loading clinical trials...
LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hamilton Health Sciences Corporation
Collaborators
NCT07575867 · Atrial Fibrillation, Stroke Prevention in Patients With Atrial Fibrillation, and more
NCT05009797 · Atrial Fibrillation
NCT06500988 · Atrial Fibrillation, Behavior
NCT07421076 · Paroxysmal Atrial Fibrillation (PAF)
NCT07490808 · Atrial Fibrillation (AF), Acute Kidney Injury
Affinity Hospital dba Grandview Medical Center
Birmingham, Alabama
Arrhythmia Research Group
Jonesboro, Arkansas
Memorial Health Services
Fountain Valley, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions